Live - How to use cardiac and oncologic markers during prostate cancer therapy

Dr Lenihan has been active in cardio-oncology and heart failure, for over 20 years. The main focus of these efforts have included hemodynamic assessments, angiogenic growth factor response, novel cardiac biomarkers as well as optimal methods to prevent or detect heart failure at the earliest stage possible in patients undergoing treatment for cancer. His current research projects include early phase clinical trials in cardio-oncology, heart failure and amyloidosis. He is the Principal Investigator of the PROTECT study looking at cardiac safety in patients undergoing proteasome inhibitor treatment for relapsed multiple myeloma and the recently completed PREDICT study, a large multicenter prospective study examining the role of cardiac biomarkers for the detection of cardiotoxicity during anthracycline based therapy. In addition, he is intimately involved in the latest treatment trials for cardiac amyloidosis. He was recently at Washington University in St Louis to enhance and expand the Cardio-Oncology Center of Excellence. He is at the forefront of concerted efforts to develop a viable Cardio-Oncology fellowship training program and continues to foster collaboration among a host of colleagues both regionally, nationally, and throughout the world. He is the current President of the International Cardio-Oncology Society (ICOS),www.IC-OS.org, which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.

Dr. Leong is Associate Professor, Department of Medicine, McMaster University. His clinical interests include cardio-oncology, frailty, multi-morbidity and echocardiography. He is Director of the McMaster University and Hamilton Health Sciences Cardio-Oncology Program. Dr. Leong completed his cardiology training, Doctor of Philosophy, Master of Public Health, and Master of Biostatistics degrees at the University of Adelaide, Australia. He has completed a post-doctorate fellowship in cardiovascular imaging at the Leiden University Medical Centre, the Netherlands, before re-locating to Canada. He is currently a Clinician Scientist of the Heart and Stroke Foundation of Canada. His research is supported by the Canadian Institutes of Health Research and the Canadian Cancer Society, and he has published over 150 manuscripts including all the leading internal medical and cardiovascular journals. His h-index is 47 with approximately 11,000 citations.

Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program. From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients. He is one of the Founding Editors of Cardio-oncology Journal. He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians. He received the Thomas Force Award in 2020.

Dr Renato D Lopes is currently the Director of Clinical Events Classification (CEC) and the Co-Director of the Integrated Clinical Events-Safety Surveillance Group. His primary research interests include investigating the impact and outcomes of atrial fibrillation complicating acute coronary syndromes. Dr Lopes completed his clinical training at the Federal University of São Paulo, and his Cardiology Fellowship at the Duke Clinical Research Institute (DCRI), serving as Chief Fellow for the research training program during his senior year.

Researcher, Centre de recherche du CHU de Québec, Centre NUTRISS (Nutrition Heath and Society) and INAF (Institute for Nutrition and Functional Foods), Université Laval.